The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers
NCT01695109 on ClinicalTrials.gov · last registry update 2012-09-27
A small phase 4 — 16 participants, against a typical 75. The sponsor logged completion for February 2012. Primary outcome, as filed: Food intake at an ad libitum buffet.
- Status
- COMPLETED
- Phase
- P4
- Drug
- liraglutideSaxenda, Victoza, Xultophy
- Sponsor
- Medical University of Vienna
- Sponsor type
- Other
- Enrollment
- 16
- Started
- 2010-11
- Primary completion
- 2012-02 actual
Observed history
No changes recorded since monitoring began on 2026-08-21. This record has held steady. If a reporting date moves, a status changes or enrollment is resized, it will appear here with the previous value alongside the new one.
Primary outcome
Food intake at an ad libitum buffet
Conditions studied
Healthy Human Male Subjects
Every field above is taken directly from the registry record. See all detected changes across the class, or the liraglutide page for this molecule’s full trial and approval history.